Donald Hooker
Stock Analyst at Keybanc
(2.48)
# 2,460
Out of 5,014 analysts
82
Total ratings
55.95%
Success rate
9.22%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $8.85 | +1,029.94% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $172.14 | +126.56% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $181.44 | -6.31% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $203.00 | +42.86% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $23.84 | +206.21% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $5.91 | +509.14% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $6.20 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $298.47 | +18.27% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $92.78 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $88.27 | -4.84% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $8.17 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $277.78 | -38.80% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $187.71 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $1.68 | +2,638.10% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $27.89 | - | 1 | Oct 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $518.69 | - | 2 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $8.85
Upside: +1,029.94%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $172.14
Upside: +126.56%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $181.44
Upside: -6.31%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $203.00
Upside: +42.86%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $23.84
Upside: +206.21%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $5.91
Upside: +509.14%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $6.20
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $298.47
Upside: +18.27%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $92.78
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $88.27
Upside: -4.84%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $8.17
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $277.78
Upside: -38.80%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $187.71
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $1.68
Upside: +2,638.10%
Oct 24, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $27.89
Upside: -
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $518.69
Upside: -